GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Jumpcan Pharmaceutical Co Ltd (SHSE:600566) » Definitions » Retained Earnings

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Retained Earnings : ¥9,693 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Hubei Jumpcan Pharmaceutical Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Hubei Jumpcan Pharmaceutical Co's retained earnings for the quarter that ended in Mar. 2024 was ¥9,693 Mil.

Hubei Jumpcan Pharmaceutical Co's quarterly retained earnings increased from Sep. 2023 (¥7,969 Mil) to Dec. 2023 (¥8,848 Mil) and increased from Dec. 2023 (¥8,848 Mil) to Mar. 2024 (¥9,693 Mil).

Hubei Jumpcan Pharmaceutical Co's annual retained earnings increased from Dec. 2021 (¥5,269 Mil) to Dec. 2022 (¥6,836 Mil) and increased from Dec. 2022 (¥6,836 Mil) to Dec. 2023 (¥8,848 Mil).


Hubei Jumpcan Pharmaceutical Co Retained Earnings Historical Data

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Jumpcan Pharmaceutical Co Retained Earnings Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,675.18 3,950.03 5,269.49 6,836.11 8,847.78

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,512.98 7,364.95 7,969.27 8,847.78 9,693.04

Hubei Jumpcan Pharmaceutical Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Business Description

Traded in Other Exchanges
N/A
Address
Heights Garden Road, Room 602 fashion, Shashi District, Jingzhou, Hubei, CHN
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatric. The company also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
Executives
Cao Wei Directors, senior managers
Zhou Qi Hua senior management
Huang Qu Rong Director
Yan Hong Quan senior management
Shi Wen Zheng senior management
Zhang Jian Min Director
Cao Long Xiang Director
Yan Yue Hua Director

Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Headlines

No Headlines